Disease Activity and Bone Mineral Density of MCP Joints in Patients with Rheumatoid and Psoriatic Arthritis: Is There a Correlation?—A Study in Patients Treated with Methotrexate and an Anti-TNFα Agent

Background. Bone damage in rheumatoid arthritis (RA) and in psoriatic arthritis (PsA) includes an accelerated bone mineral density (BMD) reduction. The objective was to evaluate BMD variations of the metacarpophalangeal joints (MCPs) in patients starting treatment with methotrexate (MTX) or etanerce...

詳細記述

保存先:
書誌詳細
主要な著者: Bertoldi, Ilaria, Filippou, Georgios, Scirè, Carlo Alberto, Picerno, Valentina, di Sabatino, Valentina, Adinolfi, Antonella, Pierguidi, Serena, Galeazzi, Mauro, Frediani, Bruno
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2013
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871921/
https://ncbi.nlm.nih.gov/pubmed/24381766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/708323
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料